Point72 Asset Management, L.P.
Position in OLMA — Olema Pharmaceuticals, Inc.
CIK 1603466
STAMFORD, CT
Position in OLMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,397,571
+$12,337,366 QoQ
Shares Held
1,070,949
+1406.1% QoQ
Ownership
1.22%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#22
of 182 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in OLMA Over Time
Shares Held
Position Value (USD)
Derivatives in OLMA
reported options exposure · as of Jun 30, 2026CallValue
$252,702
CallShares
20,200
PutValue
$27,522
PutShares
2,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. OLMA ranks #43 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in OLMA
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,522 | 2,200 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $13,397,571 | 1,070,949 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $252,702 | 20,200 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $575,526 | 38,600 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $1,060,205 | 71,107 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $352,500 | 14,100 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $7,697,250 | 307,890 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,402,642 | 245,418 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $5,420,754 | 1,441,690 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $21,400,915 | 3,670,826 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $44,027,245 | 3,687,374 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $34,753,050 | 3,211,927 | Shares | Defined | 2024-09-16 | |
| 2021-06-30 | $2,238,400 | 80,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,115,602 | 93,900 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||